Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Chemotherapeutic effect of tamoxifen on temozolomide-resistant gliomas
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Chemotherapeutic effect of tamoxifen on temozolomide-resistant gliomas'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Glioma
100%
Temozolomide
100%
U251
100%
Chemotherapeutic Effect
100%
A172
100%
U87 Cell Line
66%
Apoptosis
33%
Induced Apoptosis
33%
Clinical Trials
33%
Methylation
33%
Mitochondrial Complex I
33%
Chemotherapy
33%
Selective Estrogen Receptor Modulators
33%
Cytotoxic Activity
33%
Flow Cytometric Analysis
33%
Complex I Activity
33%
Hoechst 33342
33%
Glioblastoma
33%
Human Glioma Cell Line
33%
Estrogen Receptor-positive Breast Cancer
33%
Methylguanine Methyltransferase
33%
Glioma Cell Lines
33%
Mitochondrial Complex I Inhibition
33%
Direct Action
33%
Estrogen Receptor Modulator
33%
Complex Analysis
33%
Medicine and Dentistry
Ganglioglioma
100%
Chemotherapy
100%
Tamoxifen
100%
Temozolomide
100%
Cell Line
44%
Programmed Cell Death
22%
Glioma Cell Line
22%
U87
22%
Selective Estrogen Receptor Modulator
22%
Reduced Nicotinamide Adenine Dinucleotide Dehydrogenase (Ubiquinone)
11%
Clinical Trial
11%
Methylation
11%
Glioblastoma
11%
Estrogen Receptor Positive Breast Cancer
11%
DNA Methyltransferase
11%
Hoe 33342
11%
Pharmacology, Toxicology and Pharmaceutical Science
Temozolomide
100%
Tamoxifen
100%
Selective Estrogen Receptor Modulator
22%
Reduced Nicotinamide Adenine Dinucleotide Dehydrogenase (Ubiquinone)
11%
Clinical Trial
11%
Chemotherapy
11%
DNA Methyltransferase
11%
Glioblastoma
11%
Hoe 33342
11%
Estrogen Receptor Positive Breast Cancer
11%
Immunology and Microbiology
Cell Line
100%
Glioma Cell Line
50%
Methylation
25%